Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EMB vs GSK✓SelectedUSD · GSKEMB vs GSK performance historyLatest closeAs of-0.52%11/19
Stock and ETF performance explorer

EMB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6.4%
GSK return
+39.6%
Excess return
-33.1%
Maximum drawdown
-26.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.5%-1.6%+1.0%-0.4%
7D-1.1%-4.7%+3.6%-0.6%
30D-0.6%-4.7%+4.1%-0.1%
3M-3.7%-8.8%+5.0%-2.9%
6M-1.6%-4.6%+3.0%-1.3%
YTD-2.0%+1.0%-3.0%-2.4%
1Y-1.0%+6.9%-7.9%-2.1%
3Y+25.6%+52.5%-27.0%+17.2%
5Y+6.4%+40.3%-33.9%-2.9%
All+6.4%+39.6%-33.1%-2.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling